EGFR KINASE INHIBITOR COMBINATIONS FOR TREATING RESPIRATORY AND GASTROINTESTINAL DISORDERS
申请人:Boehringer Ingelheim International GmbH
公开号:EP1784224A2
公开(公告)日:2007-05-16
[EN] NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS<br/>[FR] NOUVELLES COMPOSITIONS PHARMACEUTIQUES POUR LE TRAITEMENT DE TROUBLES RESPIRATOIRES ET GASTRO-INTESTINAUX
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2006015775A2
公开(公告)日:2006-02-16
The present invention relates to novel pharmaceutical compositions comprising at least one EGFR kinase inhibitor and at least one additional active compound selected from beta-2 mimetics, steroids, PDE-IV inhibitors, p38 MAP kinase inhibitors, NK1 antagonists and endothelin-antagonists, processes for preparing the compositions and the use thereof as medicament in the treatment of respiratory or gastrointestinal complaints, as well as inflammatory diseases of the joints, the skin or the eyes.